• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素注射唾液腺以减少神经障碍儿童流涎的随机试验。

Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.

作者信息

Reid S M, Johnstone B R, Westbury C, Rawicki B, Reddihough D S

机构信息

Developmental Disability Research, Murdoch Childrens Research Institute, University of Melbourne, Victoria, Australia.

出版信息

Dev Med Child Neurol. 2008 Feb;50(2):123-8. doi: 10.1111/j.1469-8749.2007.02010.x.

DOI:10.1111/j.1469-8749.2007.02010.x
PMID:18201301
Abstract

The primary aim of this randomized, controlled trial was to assess the effectiveness of botulinum toxin A (BoNT-A) injections into the submandibular and parotid glands on drooling in children with cerebral palsy (CP) and other neurological disorders. Secondary aims were to ascertain the duration of any such effect and the timing of maximal response. Of the 48 participants (27 males, 21 females; mean age 11y 4mo [SD 3y 3mo], range 6-18y), 31 had a diagnosis of CP and 15 had a primary intellectual disability; 27 children were non-ambulant. Twenty-four children randomized to the treatment group received 25 units of BoNT-A into each parotid and submandibular gland. Those randomized to the control group received no treatment. The degree and impact of drooling was assessed by carers using the Drooling Impact Scale questionnaire at baseline and at monthly intervals up to 6 months postinjection/baseline, and again at 1 year. Maximal response was at 1 month at which time there was a highly significant difference in the mean scores between the groups. This difference remained statistically significant at 6 months. Four children failed to respond to the injections, four had mediocre results, and 16 had good results. While the use of BoNT-A can help to manage drooling in many children with neurological disorders, further research is needed to fully understand the range of responses.

摘要

这项随机对照试验的主要目的是评估向患有脑瘫(CP)和其他神经障碍的儿童的下颌下腺和腮腺注射A型肉毒杆菌毒素(BoNT-A)对流涎的疗效。次要目的是确定这种效果的持续时间以及最大反应的时间。48名参与者(27名男性,21名女性;平均年龄11岁4个月[标准差3岁3个月],范围6-18岁)中,31名被诊断为CP,15名患有原发性智力残疾;27名儿童不能行走。随机分配到治疗组的24名儿童每侧腮腺和下颌下腺各接受25单位的BoNT-A注射。随机分配到对照组的儿童不接受治疗。在基线时以及注射后/基线后长达6个月的每月间隔时间,以及在1年时,由护理人员使用流涎影响量表问卷评估流涎的程度和影响。最大反应出现在1个月时,此时两组的平均得分存在高度显著差异。这种差异在6个月时仍具有统计学意义。4名儿童对注射无反应,4名效果一般,16名效果良好。虽然使用BoNT-A可以帮助控制许多神经障碍儿童的流涎,但需要进一步研究以充分了解反应范围。

相似文献

1
Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.肉毒杆菌毒素注射唾液腺以减少神经障碍儿童流涎的随机试验。
Dev Med Child Neurol. 2008 Feb;50(2):123-8. doi: 10.1111/j.1469-8749.2007.02010.x.
2
Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.肉毒杆菌毒素A注射腮腺和颌下腺治疗脑瘫患儿流涎症
Dev Med Child Neurol. 2006 Nov;48(11):883-7. doi: 10.1017/S0012162206001939.
3
Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.肉毒杆菌毒素治疗流涎症的效果:一项对照临床试验。
Pediatrics. 2004 Sep;114(3):620-7. doi: 10.1542/peds.2003-1104-L.
4
Efficacy and duration of botulinum toxin treatment for drooling in 131 children.131名儿童流口水的肉毒杆菌毒素治疗效果及持续时间
Arch Otolaryngol Head Neck Surg. 2010 Sep;136(9):873-7. doi: 10.1001/archoto.2010.147.
5
Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.脑瘫患儿流涎:唾液分泌减少对日常生活及护理的影响。
Dev Med Child Neurol. 2006 Feb;48(2):103-7. doi: 10.1017/S0012162206000235.
6
Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.用A型或B型肉毒杆菌毒素成功治疗患有神经障碍的儿童流口水问题。
Neuropediatrics. 2008 Aug;39(4):200-4. doi: 10.1055/s-0028-1112115. Epub 2009 Jan 22.
7
Thickened saliva after effective management of drooling with botulinum toxin A.肉毒毒素 A 有效管理流涎后唾液变厚。
Dev Med Child Neurol. 2010 Jun;52(6):e114-8. doi: 10.1111/j.1469-8749.2009.03601.x. Epub 2010 Feb 12.
8
Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.A型肉毒毒素治疗脑瘫患者流涎的疗效、安全性及对生活质量的影响因素
Am J Phys Med Rehabil. 2017 Feb;96(2):68-76. doi: 10.1097/PHM.0000000000000525.
9
Successful management of drooling with botulinum toxin A in neurologically disabled children.肉毒杆菌毒素A成功治疗神经功能障碍儿童流口水问题。
Neuropediatrics. 2002 Dec;33(6):327-30. doi: 10.1055/s-2002-37084.
10
Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.脑瘫患儿流涎症的治疗:一项双盲安慰剂对照试验。
Clin Neurol Neurosurg. 2009 Jan;111(1):79-82. doi: 10.1016/j.clineuro.2008.09.001. Epub 2008 Nov 1.

引用本文的文献

1
The Role of Speech Therapy in Sialorrhea Management and Quality of Life: A Retrospective Study.言语治疗在流涎管理及生活质量中的作用:一项回顾性研究。
Laryngoscope Investig Otolaryngol. 2025 Feb 25;10(1):e70105. doi: 10.1002/lio2.70105. eCollection 2025 Feb.
2
Botulinum toxin type A-targeted SPP1 contributes to neuropathic pain by the activation of microglia pyroptosis.靶向A型肉毒杆菌毒素的分泌性磷蛋白1通过激活小胶质细胞焦亡促进神经性疼痛。
World J Psychiatry. 2024 Aug 19;14(8):1254-1266. doi: 10.5498/wjp.v14.i8.1254.
3
Comparing the evidence for botulinum neurotoxin injections in paediatric anterior drooling: a scoping review.
比较肉毒杆菌神经毒素注射治疗儿科流涎症的证据:范围综述。
Eur J Pediatr. 2024 Jan;183(1):83-93. doi: 10.1007/s00431-023-05309-1. Epub 2023 Nov 4.
4
Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review.A型肉毒毒素治疗小儿流涎症的管理:系统评价。
Ann Otol Rhinol Laryngol. 2023 Feb;132(2):200-206. doi: 10.1177/00034894221078365. Epub 2022 Feb 18.
5
Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: a randomized controlled trial.手术与肉毒毒素 A 治疗减少流涎和改善神经发育障碍儿童的日常生活:一项随机对照试验。
Dev Med Child Neurol. 2021 Nov;63(11):1351-1359. doi: 10.1111/dmcn.14924. Epub 2021 May 16.
6
Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.颏下导管结扎术在脑瘫儿童 A 型肉毒毒素治疗流涎中的应用。
Dev Med Child Neurol. 2020 Jul;62(7):861-867. doi: 10.1111/dmcn.14510. Epub 2020 Mar 9.
7
Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities.神经发育障碍儿童下颌下腺肉毒杆菌神经毒素 A 注射后流涎严重程度和影响的变化。
Dev Med Child Neurol. 2020 Mar;62(3):354-362. doi: 10.1111/dmcn.14391. Epub 2019 Nov 14.
8
Therapy of Sialorrhea with Botulinum Neurotoxin.肉毒杆菌神经毒素治疗流涎症
Neurol Ther. 2019 Dec;8(2):273-288. doi: 10.1007/s40120-019-00155-6. Epub 2019 Sep 21.
9
Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.肉毒毒素 A 治疗与神经障碍相关的流涎症:评估治疗效果与治疗腺体数量之间的关系。
Toxins (Basel). 2018 Jan 27;10(2):55. doi: 10.3390/toxins10020055.
10
Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.A型肉毒毒素治疗脑瘫患儿流涎:一项前瞻性纵向开放标签研究。
Toxins (Basel). 2015 Jun 30;7(7):2481-93. doi: 10.3390/toxins7072481.